Drugs in the COVID-19 pandemic: Analysis of the commercialization of azithromycin, hydroxychloroquine, ivermectin and nitazoxanide in Brazil. (2022). Research, Society and Development, 11(6), e16711628726. https://doi.org/10.33448/rsd-v11i6.28726